ClinicalTrialsFinder

Relapsed/Refractory B-cell Lymphoma Clinical Trials in Shenzhen, Guangdong

1 recruitingShenzhen, Guangdong, China

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Efficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma

Relapsed/Refractory B-cell Lymphoma
Shenzhen University General Hospital20 enrolled1 locationNCT07508605